|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_on1061860537 |
003 |
OCoLC |
005 |
20231120010324.0 |
006 |
m o d |
007 |
cr cnu|||unuuu |
008 |
181108s2018 enk ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d N$T
|d EBLCP
|d YDX
|d OPELS
|d OCLCF
|d UKMGB
|d MERER
|d OCLCQ
|d LQU
|d UKAHL
|d OCLCQ
|d S2H
|d OCLCO
|d OCLCQ
|d OCLCO
|d K6U
|d OCLCQ
|d SFB
|d OCLCQ
|
066 |
|
|
|c (S
|
015 |
|
|
|a GBB8L6145
|2 bnb
|
016 |
7 |
|
|a 019126035
|2 Uk
|
019 |
|
|
|a 1064776461
|a 1066263138
|a 1105189646
|a 1105571918
|
020 |
|
|
|a 9780128096291
|q (electronic bk.)
|
020 |
|
|
|a 0128096292
|q (electronic bk.)
|
020 |
|
|
|z 9780128094020
|
020 |
|
|
|z 0128094028
|
035 |
|
|
|a (OCoLC)1061860537
|z (OCoLC)1064776461
|z (OCoLC)1066263138
|z (OCoLC)1105189646
|z (OCoLC)1105571918
|
050 |
|
4 |
|a RC864
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
072 |
|
7 |
|a MQW
|2 bicssc
|
082 |
0 |
4 |
|a 616.34
|2 23
|
245 |
0 |
0 |
|a Pouchitis and ileal pouch disorders :
|b a multidisciplinary approach for diagnosis and management /
|c edited by Bo Shen.
|
250 |
|
|
|a First edition.
|
264 |
|
1 |
|a London :
|b Academic Press,
|c 2018.
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Online resource; title from PDF title page (EBSCO, viewed November 9, 2018).
|
505 |
0 |
|
|a Front Cover; Pouchitis and Ileal Pouch Disorders: A Multidisciplinary Approach for Diagnosis and Management; Copyright; Dedication; Contents; Contributors; Author's Biography; Preface; Chapter 1 Current Medical Therapies for Ulcerative Colitis; Introduction; Assessing Disease Severity and Response to Medical Therapy; Aminosalicylates; Oral Preparations; Rectal Preparations; Efficacy of ASA; Corticosteroids; Systemic Steroids; Targeted Steroids; Maintenance Therapy and Adverse Effects; Antimetabolites; Thiopurines; Combination Therapy; Methotrexate; Calcineurin Inhibitors; Intravenous CSA
|
505 |
8 |
|
|a Chapter 2 Indications and Preoperative Medical Management of Ulcerative Colitis Patients Undergoing Pouch SurgeryIntroduction; Indications for the Ileal Pouch; Medically Refractory UC; UC Patients With Medicine-Associated Side Effects; Colitis-Associated Neoplasia; Crohn's Colitis; Indeterminate Colitis; Familial Adenomatous Polyposis; Other Indications; Periopertive Use of Anticoagulation; Periopertive Use of Mesalamines; Periopertive Use of Corticorticosteroids; Periopertive Use of Immunomodulators; Purine Analogs; Methotrexate; Cyclosporine A
|
505 |
8 |
|
|a Periopertive Use of Antitumor Necrosis Factor AgentsPeriopertive Use of Anti-integrin Agents; Perioperative Nutrition Support; Perioperative Blood Transfusion; Summary and Recommendations; References; Chapter 3 Preoperative Evaluation and Techniques of Colectomy and Ileal Pouch Surgery; Introduction; Preoperative Evaluation; Establishing Patient Goals; Determining Candidacy for IPAA; Thromboembolic Issues; Enterostomal Preparation; Role of the Multidisciplinary IPAA Specialty Team; Shared Patient Experiences; Operative Technique of Restorative Proctocolectomy
|
505 |
8 |
|
|a Deciding Among Pouch ConfigurationsStapled vs Hand-Sewn (Mucosectomy) Anastomosis; Alternatives to IPAA; Summary and Recommendations; References; Chapter 4 Risk Factors for Short- and Long-Term Complications of Ileal Pouch Surgery; Introduction; Risk Factors for Short-Term (30 Days) Complications; Anastomotic Leak; Pelvic Abscess and Sepsis; Wound Infection; Risk Factors for Long-Term Surgical Complications; Pouch-Related Fistula; Small Bowel Obstruction; Afferent Limb Syndrome; Efferent Limb Syndrome; Non-CD Strictures; The Leak at the Tip of the "J"; Pouch Prolapse; Pouch Sinus
|
520 |
|
|
|a Pouchitis and Ileal Pouch Disorders: A Multidisciplinary Approach for Diagnosis and Management provides much needed information on the evolution of pouch surgery, pouch surgery techniques, and surgery-associated complications, including inflammatory, functional, neoplastic, and metabolic complications. The book provides information on the anatomy of the pouch, pathogenesis of pouchitis and other pouch disorders, proper diagnostic modalities, and medical, endoscopic and surgical options for those disorders. The information has been compiled from a panel of national and international leading experts in the field, including basic scientists, gastrointestinal (GI) pathologists, GI radiologists, gastroenterologists, and more.
|
650 |
|
0 |
|a Proctology.
|
650 |
|
2 |
|a Colorectal Surgery
|0 (DNLM)D003107
|
650 |
|
6 |
|a Proctologie.
|0 (CaQQLa)201-0030168
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Proctology.
|2 fast
|0 (OCoLC)fst01078105
|
700 |
1 |
|
|a Shen, Bo.,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|z 0128094028
|z 9780128094020
|w (OCoLC)1031458331
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128094020
|z Texto completo
|
880 |
8 |
|
|6 505-00/(S
|a Other Formulations of CSATacrolimus; Mammalian Target of Rapamycin Inhibitors; Mycophenolate Motefil; Monoclonal Antibodies to TNF- α; Infliximab; Other TNF Inhibitors; Anti-integrins; Vedolizumab; Natalizumab; Etrolizumab; Smoking, Nicotine, and UC; Induction Therapy; Maintenance Therapy; Altering the Microbiome in UC; Probiotics; Antibiotics; Fecal Microbiota Transplantation; Novel/Experimental Agents; MAdCAM Inhibitors; Janus Kinase Inhibitors; ICAM-1 Inhibitors; Summary and Recommendations; References; Further Reading
|